About Innogest Capital
Innogest Capital is a venture capital firm founded in 2006. It is primarily based out of Milan, Italy. As of Feb 2025, Innogest Capital has invested in 40 companies. It primarily invests in Series A round in Italy based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and Retail. Most recently it participated in the $***** Series B round of Newronika Overall, Innogest Capital portfolio has seen 12 acquisitions including key companies like CornerJob, Everli and Silicon Biosystems. A lot of funds co-invest with Innogest Capital, with names like CDP Venture Capital sharing a substantial percentage of its portfolio. Innogest Capital has team of 10 people including 4 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 3 more
Portfolio Soonicorns
Innogest Capital's List of Top Investments
Innogest Capital has a portfolio of 40 companies. Their most notable investments are in Drexcode and MIOAssicuratore.Their portfolio spans across Italy, United States, Spain and 3 more locations. They have invested in Life Sciences, Enterprise Applications, Retail and 16 other sectors, across stages such as Series A, Seed and 3 more. Here is the list of top investments by Innogest Capital:
1. CornerJob
Geolocalized app-based blue-collar job search platform. It is an app-based job search platform that matches blue-collar job seekers and employers based on their locality. Job seekers and companies can use the platform to create their profiles, apply for jobs, and post offerings. Offers a chat service where job seekers and companies can communicate. Once contacted by a job seeker the employer has 24 hours to communicate back before it goes out of date. Its app is available for both Android and iOS users.
Key facts about CornerJob
- Founded Year: 2015
- Location: Cassa de la Selva (Spain)
- Stage: Acquired
- Total Funding till date: $57M
- Employee Count: 10 - 49 as on Mar 01, 2026
- Investors: Northzone, #adm ventures and 26 Others
- Latest Funding Round: Series C, Aug 01, 2017, $*****
- Highlight: Acquired
2. Everli
Everli is an online marketplace offering groceries. The company claims that users can browse through the nearby supermarkets and order their products after which their in-house delivery team will deliver the products. Their app is available for both Android and iOS users.
Key facts about Everli
- Founded Year: 2014
- Location: Milan (Italy)
- Stage: Acquired
- Total Funding till date: $155M
- Employee Count: 232 as on Aug 31, 2026
- Investors: 360 Capital Partners, Verlinvest and 18 Others
- Latest Funding Round: Series C, Mar 31, 2022, $*****
- Highlight: Acquired
3. Empatica
Developer of a wristband to monitor physiological signals. The E4 wristband for researchers measures blood volume pulse, electrodermal activity, skin temperature and activity. It also offers Embrace, a wristband to monitor physiological stress, arousal, sleep and physical activity which provides seizure monitoring.
Key facts about Empatica
- Founded Year: 2011
- Location: Milano (Italy)
- Stage: Series B
- Total Funding till date: $30.9M
- Employee Count: 140 as on Sep 30, 2026
- Investors: RA Capital Management, Sanofi Ventures and 5 Others
- Latest Funding Round: Series B, Nov 22, 2022, $*****
- Highlight: Editors' Pick
_1580125123202.png?format=webp&height=120&width=120){kind=logo}
4. Pi-Cardia
Pi-cardia manufactures non-implant devices for valve repair. The product Leaflex provides lines that create separation between the calcium deposits on the two sides of the scoring line, in order to regain leaflets flexibility, allow their mobility and improve valve hemodynamics.
Key facts about Pi-Cardia
- Founded Year: 2009
- Location: Rehovot (Israel)
- Stage: Series D
- Total Funding till date: $40M
- Employee Count: 100 as on Sep 30, 2026
- Investors: Kreos Capital, Accelmed and 9 Others
- Latest Funding Round: Series D, Sep 01, 2026, $*****
- Highlight: Editors' Pick
5. Newronika
Newronika has developed a medical device for neurodegenerative diseases. The company has developed a product called AlphaDBS which is a closed-loop deep brain neuromodulation system used to interpret the bioelectrical neuronal activity. The company has also developed another product known as WebBioBank which is a web-based platform used by the researchers to collect, analyze, and interpret biosignals including also electronic health records data for patients going through neuromodulation treatment.
Key facts about Newronika
- Founded Year: 2016
- Location: Cologno Monzese (Italy)
- Stage: Series B
- Total Funding till date: $25.2M
- Employee Count: 27 as on Sep 30, 2026
- Investors: Intesa Sanpaolo, Indaco Venture Partners and 9 Others
- Latest Funding Round: Series B, Feb 13, 2025, $*****
- Highlight: Editors' Pick
Innogest Capital's Year-on-Year Investment Trends
Innogest Capital has invested in 40 companies over the last 19 years, with an average of 1 new investment annually in the last 10 years. In 2025, it made 1 investment. Its most recent first time investment was in BetaGlue Technologies and most recent follow-on round was in Newronika.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 1 | 1 |
2024 | 0 | 0 | 0 |
2023 | 0 | 1 | 1 |
2022 | 1 | 0 | 1 |
2021 | 1 | 3 | 4 |
2020 | 0 | 2 | 2 |
2019 | 3 | 3 | 6 |
2018 | 1 | 2 | 3 |
2017 | 4 | 1 | 5 |
Innogest Capital's Investments by Stage
Innogest Capital has made 14 investments in Series A stage with an average round size of $6.5M, 12 investments in Seed stage with an average round size of $1.67M, 4 investments in Series B stage with an average round size of $16.9M, 2 investments in Series C stage with an average round size of $6.5M and 2 investments in Unattributed stage with an average round size of $5.44M.Stage of entry | No. of Investments |
|---|---|
Series A | 14 |
Seed | 12 |
Series B | 4 |
Series C | 2 |
Unattributed | 2 |
Note: We have considered here, only first round of investments
Innogest Capital's Investments by Sector
Innogest Capital has a diverse portfolio, with companies operating in the Life Sciences, Consumer, High Tech, Enterprise Applications and FinTech. Notably, it has invested in 30 Tech companies, 23 Enterprise (B2B) companies, 13 Consumer (B2C) companies and at least 11 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 14 |
Consumer | 6 |
High Tech | 4 |
Enterprise Applications | 3 |
FinTech | 3 |
Others | 20 |
Note: We have considered here, only first round of investments
Innogest Capital's Investments by Geography
Innogest Capital has made most investments in Italy (24), followed by United States where it has made 4 investments.Country | No. of Investments |
|---|---|
Italy | 24 |
United States | 4 |
Spain | 3 |
Israel | 1 |
Singapore | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
Innogest Capital's recent investments
Innogest Capital has not made any investment in 2026 so far.Here are the most recent investments by Innogest Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 13, 2025 | Italy | Series B | 9549 | ||
Oct 13, 2023 | Italy | Series A | 9814 | [+3] | |
Jul 20, 2022 | Italy | Series A | 2750 | [+7] | |
Sep 23, 2021 | Italy | Series C | 2562 | [+6] | |
Apr 13, 2021 | Italy | Series B | 6471 |
Acquired companies in Innogest Capital's Portfolio
12 companies from Innogest Capital's portfolio have been acquired. The most recent acquisition was Everli in Feb 2024 by Palella Holdings for $*****.Here are Innogest Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Feb 21, 2024 | Jun 18, 2016 | Series A | 1835 | |
Jul 24, 2023 | Jul 2013 | Series B | 3689 | |
May 05, 2023 | Dec 21, 2015 | Series A | 3912 | |
Sep 20, 2022 | Aug 14, 2019 | Series A | 5413 | |
Jan 10, 2022 | Jan 2021 | Seed | 5483 |
Team profile of Innogest Capital
Innogest Capital has a team of 10 members including 4 Partners and 5 Venture Partners located in Italy and United States. Innogest Capital's team does not sit on the board of any company as of now.Here is a list of all team members in Innogest Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Milan | - | ||
Partner | San Diego | - | - | |
Partner | Dallas | - | ||
Partner | Milan | - | - | |
Venture Partner | Turin | - | ||
Venture Partner | Milan | - | - | |
Venture Partner | San Francisco | - | - | |
Venture Partner | - | - | ||
Venture Partner | Milan | - |
Co-investors of Innogest Capital
Over the past 19 years, 126 investors have co-invested in Innogest Capital's portfolio companies. This includes funds and angels.
- Invested before Innogest Capital: Caixa Capital Risc, 360 Capital Partners and 32 others have invested in rounds before Innogest Capital. There are 2 companies where Caixa Capital Risc has invested before Innogest Capital and 2 companies where 360 Capital Partners has invested before Innogest Capital.
- Top Co-investors of Innogest Capital: 43 investors entered a company along with Innogest Capital. These include investors like CDP Venture Capital (3 companies).
- Invested after Innogest Capital: A total of 49 investors have invested in Innogest Capital's portfolio after their investments. Top Investors include Europa (6 companies), EIC Fund (3 companies) and Sofinnova Partners (2 companies).
Recent News related to Innogest Capital
•
Newronika Closes €13.6M Series B FinancingFinSMEs•Feb 13, 2025•Newronika, TNT Capital, Wille Finance, Innogest Capital and 3 others
•
Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS PlatformPR Newswire•Feb 13, 2025•Newronika, ENEA Tech e Biomedical, Indaco Venture Partners, Innogest Capital and 2 others
•
•
GreenBone Ortho S.p.A.’s €10 Million Series B FinancingGlobal Legal Chronicle•May 03, 2021•HI-LEX, 3B Future Health Fund, CDP Venture Capital, GreenBone and 3 others
•
Start-up GreenBone closes a EUR10m Series B roundPrivate Equity Wire•Apr 13, 2021•GreenBone, 3B Future Health Fund, Innogest Capital, META Group and 2 others
•
Everli’s $100 Million Series C Financing RoundGlobal Legal Chronicle•Apr 06, 2021•Everli, White & Case, PwC TLS, Verlinvest and 11 others
•
MedLumics Closes Upsized EUR 18M Financing RoundFinSMEs•Feb 10, 2021•MedLumics, Kurma Partners, Asabys Partners, VI Partners and 4 others
•
Primomiglio, CDP Venture, Innogest in €5.8m round for SardexUnquote•Jul 24, 2020•Sardex, Cassa depositi e prestiti Group, Primomiglio SGR, Innogest Capital
•
Milan-based Supermercato24 raises €11 million to expand its e-grocery marketplace in EuropeEU-Startups•Jan 31, 2020•Supermercato24, DIP Capital, 360 Capital Partners, Innogest Capital and 1 other
•
